Skip to main
GRDN

GRDN Stock Forecast & Price Target

GRDN Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Guardian Pharmacy Service is a leading provider in the fragmented long-term care pharmacy industry, with robust technology assets and strong financial flexibility. Its local leadership model and focus on customer service/relationships drive organic growth, while M&A and greenfield expansion opportunities provide potential for further growth. The company's recent vaccine outperformance and solid financials also support a positive outlook.

Bears say

Guardian Pharmacy Service is a financially stable company with a robust M&A pipeline and clean balance sheet. However, the company's focus on organic growth and disciplined M&A strategy may hinder its ability to fully capitalize on potential opportunities, including acquiring assets from Omnicare. Additionally, the company's strong cash flow and financial flexibility could support continued investment and growth. While we have adjusted our estimates and raised our price target, our negative outlook is due to concerns about potential missed opportunities and limited potential for short-term stock growth.

GRDN has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Guardian Pharmacy Services Inc (GRDN) Forecast

Analysts have given GRDN a Strong Buy based on their latest research and market trends.

According to 5 analysts, GRDN has a Strong Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Guardian Pharmacy Services Inc (GRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.